A sexual health quality improvement program (SHIMMER) triples chlamydia and gonorrhoea testing rates among young people attending Aboriginal primary health care services in Australia

Simon Graham, Rebecca J. Guy, Handan C. Wand, John M. Kaldor, Basil Donovan, Janet Knox, Debbie McCowen, Patricia Bullen, Julie Booker, Chris O'Brien, Kristine Garrett, James S. Ward

Research output: Contribution to journalArticle

6 Citations (Scopus)

Abstract

Background: In Australia, chlamydia is the most commonly notifiable infection and over the past ten years chlamydia and gonorrhoea notification rates have increased. Aboriginal compared with non-Aboriginal Australians have the highest notifications rates of chlamydia and gonorrhoea. Regular testing of young people for chlamydia and gonorrhoea is a key prevention strategy to identify asymptomatic infections early, provide treatment and safe sex education. This study evaluated if a sexual health quality improvement program (QIP) known as SHIMMER could increase chlamydia and gonorrhoea testing among young people attending four Aboriginal primary health care services in regional areas of New South Wales, Australia. Methods: We calculated the proportion of 15-29 year olds tested and tested positivity for chlamydia and gonorrhoea in a 12-month before period (March 2010-February 2011) compared with a 12-month QIP period (March 2012-February 2013). Logistic regression was used to assess the difference in the proportion tested for chlamydia and gonorrhoea between study periods by gender, age group, Aboriginal status and Aboriginal primary health service. Odds ratios (OR) and their 95% confidence intervals (CIs) were calculated with significance at p<0.05. Results: In the before period, 9% of the 1881 individuals were tested for chlamydia, compared to 22% of the 2259 individuals in the QIP period (OR): 1.43, 95 % CI: 1.22-1.67). From the before period to the QIP period, increases were observed in females (13 % to 25%, OR: 1.32, 95 % CI: 1.10-1.59) and males (3 % to 17%, OR: 1.85, 95 % CI: 1.36-2.52). The highest testing rate in the QIP period was in 15-19 year old females (16 % to 29%, OR: 1.02, 95 % CI: 0.75-1.37), yet the greatest increase was in 20-24 year olds males (3 % to 19%, OR: 1.65, 95 % CI: 1.01-2.69). Similar increases were seen in gonorrhoea testing. Overall, there were 70 (11%) chlamydia diagnoses, increasing from 24 in the before to 46 in the QIP period. Overall, 4 (0.7%) gonorrhoea tests were positive. Conclusions: The QIP used in SHIMMER almost tripled chlamydia and gonorrhoea testing in young people and found more than twice as many chlamydia infections. The QIP could be used by other primary health care centres to increase testing among young people.

LanguageEnglish
Article number370
JournalBMC Infectious Diseases
Volume15
Issue number1
DOIs
Publication statusPublished - 2 Sep 2015

ASJC Scopus subject areas

  • Infectious Diseases

Cite this

Graham, Simon ; Guy, Rebecca J. ; Wand, Handan C. ; Kaldor, John M. ; Donovan, Basil ; Knox, Janet ; McCowen, Debbie ; Bullen, Patricia ; Booker, Julie ; O'Brien, Chris ; Garrett, Kristine ; Ward, James S. / A sexual health quality improvement program (SHIMMER) triples chlamydia and gonorrhoea testing rates among young people attending Aboriginal primary health care services in Australia. In: BMC Infectious Diseases. 2015 ; Vol. 15, No. 1.
@article{76683338eee1455fb8d7c37739301a98,
title = "A sexual health quality improvement program (SHIMMER) triples chlamydia and gonorrhoea testing rates among young people attending Aboriginal primary health care services in Australia",
abstract = "Background: In Australia, chlamydia is the most commonly notifiable infection and over the past ten years chlamydia and gonorrhoea notification rates have increased. Aboriginal compared with non-Aboriginal Australians have the highest notifications rates of chlamydia and gonorrhoea. Regular testing of young people for chlamydia and gonorrhoea is a key prevention strategy to identify asymptomatic infections early, provide treatment and safe sex education. This study evaluated if a sexual health quality improvement program (QIP) known as SHIMMER could increase chlamydia and gonorrhoea testing among young people attending four Aboriginal primary health care services in regional areas of New South Wales, Australia. Methods: We calculated the proportion of 15-29 year olds tested and tested positivity for chlamydia and gonorrhoea in a 12-month before period (March 2010-February 2011) compared with a 12-month QIP period (March 2012-February 2013). Logistic regression was used to assess the difference in the proportion tested for chlamydia and gonorrhoea between study periods by gender, age group, Aboriginal status and Aboriginal primary health service. Odds ratios (OR) and their 95{\%} confidence intervals (CIs) were calculated with significance at p<0.05. Results: In the before period, 9{\%} of the 1881 individuals were tested for chlamydia, compared to 22{\%} of the 2259 individuals in the QIP period (OR): 1.43, 95 {\%} CI: 1.22-1.67). From the before period to the QIP period, increases were observed in females (13 {\%} to 25{\%}, OR: 1.32, 95 {\%} CI: 1.10-1.59) and males (3 {\%} to 17{\%}, OR: 1.85, 95 {\%} CI: 1.36-2.52). The highest testing rate in the QIP period was in 15-19 year old females (16 {\%} to 29{\%}, OR: 1.02, 95 {\%} CI: 0.75-1.37), yet the greatest increase was in 20-24 year olds males (3 {\%} to 19{\%}, OR: 1.65, 95 {\%} CI: 1.01-2.69). Similar increases were seen in gonorrhoea testing. Overall, there were 70 (11{\%}) chlamydia diagnoses, increasing from 24 in the before to 46 in the QIP period. Overall, 4 (0.7{\%}) gonorrhoea tests were positive. Conclusions: The QIP used in SHIMMER almost tripled chlamydia and gonorrhoea testing in young people and found more than twice as many chlamydia infections. The QIP could be used by other primary health care centres to increase testing among young people.",
author = "Simon Graham and Guy, {Rebecca J.} and Wand, {Handan C.} and Kaldor, {John M.} and Basil Donovan and Janet Knox and Debbie McCowen and Patricia Bullen and Julie Booker and Chris O'Brien and Kristine Garrett and Ward, {James S.}",
year = "2015",
month = "9",
day = "2",
doi = "10.1186/s12879-015-1107-5",
language = "English",
volume = "15",
journal = "BMC Infectious Diseases",
issn = "1471-2334",
publisher = "BioMed Central",
number = "1",

}

A sexual health quality improvement program (SHIMMER) triples chlamydia and gonorrhoea testing rates among young people attending Aboriginal primary health care services in Australia. / Graham, Simon; Guy, Rebecca J.; Wand, Handan C.; Kaldor, John M.; Donovan, Basil; Knox, Janet; McCowen, Debbie; Bullen, Patricia; Booker, Julie; O'Brien, Chris; Garrett, Kristine; Ward, James S.

In: BMC Infectious Diseases, Vol. 15, No. 1, 370, 02.09.2015.

Research output: Contribution to journalArticle

TY - JOUR

T1 - A sexual health quality improvement program (SHIMMER) triples chlamydia and gonorrhoea testing rates among young people attending Aboriginal primary health care services in Australia

AU - Graham, Simon

AU - Guy, Rebecca J.

AU - Wand, Handan C.

AU - Kaldor, John M.

AU - Donovan, Basil

AU - Knox, Janet

AU - McCowen, Debbie

AU - Bullen, Patricia

AU - Booker, Julie

AU - O'Brien, Chris

AU - Garrett, Kristine

AU - Ward, James S.

PY - 2015/9/2

Y1 - 2015/9/2

N2 - Background: In Australia, chlamydia is the most commonly notifiable infection and over the past ten years chlamydia and gonorrhoea notification rates have increased. Aboriginal compared with non-Aboriginal Australians have the highest notifications rates of chlamydia and gonorrhoea. Regular testing of young people for chlamydia and gonorrhoea is a key prevention strategy to identify asymptomatic infections early, provide treatment and safe sex education. This study evaluated if a sexual health quality improvement program (QIP) known as SHIMMER could increase chlamydia and gonorrhoea testing among young people attending four Aboriginal primary health care services in regional areas of New South Wales, Australia. Methods: We calculated the proportion of 15-29 year olds tested and tested positivity for chlamydia and gonorrhoea in a 12-month before period (March 2010-February 2011) compared with a 12-month QIP period (March 2012-February 2013). Logistic regression was used to assess the difference in the proportion tested for chlamydia and gonorrhoea between study periods by gender, age group, Aboriginal status and Aboriginal primary health service. Odds ratios (OR) and their 95% confidence intervals (CIs) were calculated with significance at p<0.05. Results: In the before period, 9% of the 1881 individuals were tested for chlamydia, compared to 22% of the 2259 individuals in the QIP period (OR): 1.43, 95 % CI: 1.22-1.67). From the before period to the QIP period, increases were observed in females (13 % to 25%, OR: 1.32, 95 % CI: 1.10-1.59) and males (3 % to 17%, OR: 1.85, 95 % CI: 1.36-2.52). The highest testing rate in the QIP period was in 15-19 year old females (16 % to 29%, OR: 1.02, 95 % CI: 0.75-1.37), yet the greatest increase was in 20-24 year olds males (3 % to 19%, OR: 1.65, 95 % CI: 1.01-2.69). Similar increases were seen in gonorrhoea testing. Overall, there were 70 (11%) chlamydia diagnoses, increasing from 24 in the before to 46 in the QIP period. Overall, 4 (0.7%) gonorrhoea tests were positive. Conclusions: The QIP used in SHIMMER almost tripled chlamydia and gonorrhoea testing in young people and found more than twice as many chlamydia infections. The QIP could be used by other primary health care centres to increase testing among young people.

AB - Background: In Australia, chlamydia is the most commonly notifiable infection and over the past ten years chlamydia and gonorrhoea notification rates have increased. Aboriginal compared with non-Aboriginal Australians have the highest notifications rates of chlamydia and gonorrhoea. Regular testing of young people for chlamydia and gonorrhoea is a key prevention strategy to identify asymptomatic infections early, provide treatment and safe sex education. This study evaluated if a sexual health quality improvement program (QIP) known as SHIMMER could increase chlamydia and gonorrhoea testing among young people attending four Aboriginal primary health care services in regional areas of New South Wales, Australia. Methods: We calculated the proportion of 15-29 year olds tested and tested positivity for chlamydia and gonorrhoea in a 12-month before period (March 2010-February 2011) compared with a 12-month QIP period (March 2012-February 2013). Logistic regression was used to assess the difference in the proportion tested for chlamydia and gonorrhoea between study periods by gender, age group, Aboriginal status and Aboriginal primary health service. Odds ratios (OR) and their 95% confidence intervals (CIs) were calculated with significance at p<0.05. Results: In the before period, 9% of the 1881 individuals were tested for chlamydia, compared to 22% of the 2259 individuals in the QIP period (OR): 1.43, 95 % CI: 1.22-1.67). From the before period to the QIP period, increases were observed in females (13 % to 25%, OR: 1.32, 95 % CI: 1.10-1.59) and males (3 % to 17%, OR: 1.85, 95 % CI: 1.36-2.52). The highest testing rate in the QIP period was in 15-19 year old females (16 % to 29%, OR: 1.02, 95 % CI: 0.75-1.37), yet the greatest increase was in 20-24 year olds males (3 % to 19%, OR: 1.65, 95 % CI: 1.01-2.69). Similar increases were seen in gonorrhoea testing. Overall, there were 70 (11%) chlamydia diagnoses, increasing from 24 in the before to 46 in the QIP period. Overall, 4 (0.7%) gonorrhoea tests were positive. Conclusions: The QIP used in SHIMMER almost tripled chlamydia and gonorrhoea testing in young people and found more than twice as many chlamydia infections. The QIP could be used by other primary health care centres to increase testing among young people.

UR - http://www.scopus.com/inward/record.url?scp=84940491399&partnerID=8YFLogxK

U2 - 10.1186/s12879-015-1107-5

DO - 10.1186/s12879-015-1107-5

M3 - Article

VL - 15

JO - BMC Infectious Diseases

T2 - BMC Infectious Diseases

JF - BMC Infectious Diseases

SN - 1471-2334

IS - 1

M1 - 370

ER -